Devices and methods for enrichment and alteration of circulating tumor cells and other particles

• US 20070026419A1
• Filed: 12/29/2005
• Published: 02/01/2007
• Est. Priority Date: 07/29/2005
• Status: Abandoned Application

• Current Assignee: CELLective Dx Corporation
• Original Assignee: CELLective Dx Corporation
• Inventors: Fuchs, Martin, Huang, Yi-Shuian, Wang, Ying-Xin
• Application Number:
  US11/324,108
• Publication Number:
  US 20070026419A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: B01L 2200/0647 Handling flowable solids, e.g. microscopic beads, cells, particles
• CPC Class Codes: B01L 2300/0636 Integrated biosensor, microarrays
• CPC Class Codes: B01L 2300/0816 Cards, e.g. flat sample carriers usually with flow in two horizontal directions
• CPC Class Codes: B01L 2300/0864 comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
• CPC Class Codes: B01L 2400/0409 centrifugal forces
• CPC Class Codes: B01L 2400/086 using baffles or other fixed flow obstructions
• CPC Class Codes: B01L 3/502746 characterised by the means for controlling flow resistance, e.g. flow controllers, baffles B01L3/502738 takes precedence
• CPC Class Codes: B01L 3/502761 specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules investigating characteristics of particles G01N15/00
• CPC Class Codes: B82Y 10/00 Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
• CPC Class Codes: B82Y 5/00 Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
• CPC Class Codes: G01N 2800/52 Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
• CPC Class Codes: G01N 33/54366 Apparatus specially adapted for solid-phase testing

Abstract

The invention features devices and methods for detecting, enriching, and analyzing circulating tumor cells and other particles. The invention further features methods of diagnosing a condition, e.g., cancer, in a subject by analyzing a cellular sample from the subject.

Claims

1. A two-dimensional array of obstacles that form a network of gaps, wherein said array of obstacles comprises a plurality of rows, each successive row being offset by less than half of the period of the previous row, and wherein at least 70% of gaps between obstacles each has a length approximately equal to a first length parameter and at most 30% of gaps between obstacles each has a length approximately equal to a second length parameter, wherein said first length parameter is larger than said second length parameter.

2. The array of claim 1, wherein said gaps having a length approximately equal to said second length parameter are distributed throughout said array.

3. The array of claim 1, wherein said distribution is uniform.

4. The array of claim 1, wherein said distribution is non-uniform.

5. The array of claim 1, wherein said second length parameter is sized to capture a cell of interest larger than a predetermined size from a cellular sample.

6. The array of claim 1, wherein said array is coupled to a substrate.

7. The array of claim 6, wherein said substrate comprises plastic.

8. The array of claim 1, wherein said array comprises a microfluidic gap.

9. The array of claim 1, wherein said first length parameter is at least 50% larger than said second length parameter.

10. The array of claim 1, wherein said first length parameter is between 30 and 100 microns.

11. The array of claim 1, wherein said second length parameter is between 10 and 50 microns.

12. The array of claim 1, wherein at least 80% of said gaps each has a length approximately equal to said first length.

13. The array of claim 1, wherein each of said obstacles has approximately the same size.

14. The array of claim 1, wherein at least 70% of said obstacles has approximately the same size.

15. The array of claim 1, wherein at least 70% of said gaps between obstacles in each row each has a length approximately equal to said first length parameter and up to 30% of said gaps between obstacles in each row each has a length approximately equal to said second length parameter, wherein said first length parameter is longer than said second length parameter.

16. The array of claim 1, wherein at least 80% of said gaps between obstacles each has a length approximately equal to said first length parameter and at most 20% of said gaps between said obstacles each has a length approximately equal to said second length parameter.

35. The array of claim 1, wherein said array is coupled to one or more binding moieties that selectively bind one or more cells.

36. The array of claim 35, wherein said binding moieties comprise an antibody that selectively binds one or more epithelial cells, cancer cells, bone marrow cells, fetal cells, progenitor cells, stem cells, foam cells, mesenchymal cells, immune system cells, endothelial cells, endometrial cells, connective tissue cells, trophoblasts, bacteria, fungi, or pathogens.

37. The array of claim 1, wherein said array is coupled to one or more binding moieties that selectively bind one or more cell surface cancer markers.

38. The array of claim 37, wherein said cell surface markers are selected from the group consisting of EpCAM, E-Cadherin, Mucin-1, Cytokeratin 8, EGFR, and leukocyte associated receptor (LAR).

39. The array of claim 1, wherein said array is coupled to a substrate.

40. The array of claim 1, wherein said array is in a receptacle.

41. The array of claim 40, wherein said receptacle is coupled to a transparent cover.

17. A two-dimensional array of obstacles that form a network of gaps, wherein said array of obstacles comprises a plurality of rows, each successive row being offset by less than half of the period of the previous row, and wherein at most 20% of said obstacles'"'"' centers are unaligned with the centers of the remaining obstacles in their row.

18. The array of claim 17, wherein said obstacles with unaligned centers are distributed uniformly.

19. The array of claim 17, wherein said obstacles with unaligned centers are distributed non-uniformly.

20. A two-dimensional array of obstacles that form a network of gaps, wherein said array of obstacles comprises a plurality of rows, each successive row being offset by less than half of the period of the previous row, and wherein at least 80% of said obstacles each has a cross-sectional area approximately equal to a first area parameter and at most 20% of said obstacles each has a cross-sectional area approximately equal to a second area parameter.

21. The array of claim 20, wherein said second area parameter is larger than said first area parameter.

22. The array of claim 20, wherein at least one obstacle having a cross-sectional area approximately equal to said first area parameter has an asymmetrical cross-section.

23. The array of claim 20, wherein at least one obstacle having a cross-sectional area approximately equal to said second area parameter has an asymmetrical cross-section.

24. A two-dimensional array of obstacles comprising a first subarray of obstacles and a second subarray of obstacles, wherein each of said subarrays of obstacles comprises a first gap between two obstacles in said subarray, and wherein said two-dimensional array comprises an interface between said first subarray and said second subarray, said interface comprising a restricted gap smaller than said first gap.

25. The array of claim 24, wherein said array is coupled to a substrate.

26. The array of claim 25, wherein said substrate comprises plastic.

27. The array of claim 24, wherein said array comprises a microfluidic gap.

28. The array of claim 24, wherein said subarrays are two-dimensional.

29. The array of claim 24, wherein said subarrays are staggered.

30. The array of claim 29, wherein said subarrays are staggered periodically or uniformly.

31. The array of claim 24, wherein each of said subarrays comprise between 6 and 20 obstacles.

32. The array of claim 24, wherein said first gap is at least 40 microns.

33. The array of claim 24, wherein the diameter of said obstacles is between 25 and 200 microns.

34. The array of claim 24, wherein said restricted gap is less than 60 microns.

42. A device comprising:

a) a two-dimensional array of obstacles that form a network of gaps, wherein said array of obstacles comprises a plurality of rows, each successive row being offset by less than half of the period of the previous row, and wherein at least 70% of gaps between obstacles each has a length approximately equal to a first length parameter and at most 30% of gaps between obstacles each has a length approximately equal to a second length parameter, wherein said first length parameter is longer than said second length parameter;

b) a sample reservoir fluidically coupled to said array; and

c) a detector fluidically coupled to said array.

43. The device of claim 42, wherein said detector comprises a microscope, a cell counter, a magnet, a biocavity laser, a mass spectrometer, a PCR device, an RT-PCR device, a matrix, a microarray, or a hyperspectral imaging system.

44. A method for removing an analyte from a cellular sample, said method comprising processing said cellular sample using a device comprising:

a) a two-dimensional array of obstacles that form a network of gaps, wherein said array of obstacles comprises a plurality of rows, each successive row being offset by less than half of the period of the previous row, and wherein at least 70% of gaps between obstacles each has a length approximately equal to a first length parameter and at most 30% of gaps between obstacles each has a length approximately equal to a second length parameter, wherein said first length parameter is longer than said second length parameter;

b) a sample reservoir fluidically coupled to said array; and

c) a detector fluidically coupled to said array.

45. The method of claim 44, wherein said processing is continuous.

46. The method of claim 44, wherein said processing occurs ex vivo.

47. The method of claim 44, wherein said processing occurs in vivo.

48. The method of claim 44, further comprising releasing said analyte from said device by applying a hypertonic solution to said device.

49. The method of claim 48, further comprising detecting said analyte in the effluent from said device.

50. A device for the enrichment of a first analyte from a fluid sample, said device comprising a two-dimensional array of obstacles that form a network of gaps, wherein said array of obstacles comprises a plurality of rows, said rows distributed on a surface to create fluid flow paths through said device, wherein at least 70% of said flow paths each has a width approximately equal to a first width parameter and at most 30% of said flow paths each has a width approximately equal to a second, smaller width parameter.

51. The device of claim 50, wherein said flow paths each having a width approximately equal to said second width parameter are distributed throughout said device either uniformly or non-uniformly.

52. The device of claim 50, wherein said second width parameter is sized to capture said first analyte within said flow paths of said second width parameter.

53. The device of claim 52, further comprising an inlet and an outlet.

54. The device of claim 53, wherein a region of obstacles with flow path widths equal to or smaller than said second width surrounds said outlet.

55. The device of claim 54, wherein said device has three two-dimensional arrays fluidly connected in series, and the percentage of said flow paths of said second width increases in the direction of flow of fluid through said device.